Adjust Font Increase Font Decrease Font
  • Email
  • Print
  • RSS Feed

Media Releases

PhRMA Statement on India Supreme Court Decision on Glivec
WASHINGTON, D.C. (April 1, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John Castellani issued the following statement today: “PhRMA is very disappointed with the Indian Supreme Court’s decision to deny a patent on Glivec. This decision marks yet another example of the deteriorating innovation environment in India.  Innovation is critical in meeting unmet needs of patients and is particularly relevant in the context of changing healthcare systems. In order to solve the real health challenges of India’s patients, it is critically important that India promote a policy environment that supports continued research and development of new medicines for the health of patients in India and worldwide. Protecting intellectual...
Read more

Latest Releases

PhRMA Statement on Bloomberg Article
9/19/2012
Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement today: “An article published today by Bloomberg does not accurately reflect PhRMA’s position on Medicare Part D or other health care policy issues. The article is based on improperly obtained internal documents that were in draft form. The documents do not contain official PhRMA policy positions, which are set by the organization’s Board of Directors.
More
PhRMA Announces Two New Research Associate Members
9/14/2012
Ipsen Biopharmaceuticals and Onyx Pharmaceuticals Join PhRMA as Research Associate Members
The Pharmaceutical Research and Manufacturers of America (PhRMA) announced today that two companies – Ipsen Biopharmaceuticals and Onyx Pharmaceuticals – have joined the association as new research associate members. PhRMA’s Board of Directors recently approved the membership expansion.
More
From Setbacks to Stepping Stones: Alzheimer’s disease
9/12/2012
As knowledge of Alzheimer’s increases, hope remains high for millions of affected patients and caregivers with nearly 100 medicines in the pipeline
The Pharmaceutical Research and Manufacturers of America (PhRMA) released two new reports at its first annual Research and Hope Awards ceremony, which celebrated advancements made in research and patient care for Alzheimer’s disease. The reports detail how obstacles play a role in moving Alzheimer’s research forward, as well as the progress that is being made to help confront this complicated disease.
More
Researchers and Patient Advocates Honored with PhRMA Award
9/7/2012
Recipients recognized for outstanding contributions to the fight against Alzheimer’s disease
The Pharmaceutical Research and Manufacturers of America (PhRMA) announced today the recipients of the first annual Research and Hope Awards. This year’s award honors outstanding achievements in academia, the biopharmaceutical research sector, as well as the patient and caregiving communities to help advance medical progress and patient care for Alzheimer’s disease.
More
PhRMA to Bestow New Research and Hope Award
8/27/2012
More
PhRMA Statement on Flawed British Medical Journal Analysis
8/9/2012
PhRMA SVP Matthew Bennett issued a statement today on a recent analysis in the British Medical Journal.
More

Subscribe to our Email Updates